Avicanna Raises $600K in Non-Brokered Private Placement

Deal Summary

Avicanna Inc., a biopharmaceutical company, announced the closing of a non‑brokered private placement of 4,000,014 units at $0.15 per unit, generating $600,002 in gross proceeds. The units consist of a common share and a half warrant, subject to a four‑month hold period. Proceeds will be used for working capital, manufacturing, and research and development.